Moxastine theoclate acts by blocking histamine H₁ receptors, thereby reducing common allergic symptoms including sneezing, itching, rhinorrhea, and urticaria. Due to its ability to cross the blood–brain barrier, it exhibits sedative and anticholinergic effects, which are characteristic of first-generation antihistamines. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include moxastine teoclate and Mephenhydrinate. Its PubChem CID is 88998.
Moxastine theoclate
| CAS No | 21661-62-1 |
|---|---|
| Molecular Formula | C25H30ClN5O3 |
| Molecular Weight | 484.00 g/mol |
| Synonyms | 8-chloro-1,3-dimethyl-7H-purine-2,6-dione;2-(1,1-diphenylethoxy)-N,N-dimethylethanamine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Moxastine theoclate acts by blocking histamine H₁ receptors, thereby reducing common allergic symptoms including sneezing, itching, rhinorrhea, and urticaria.
The listed CAS number is 21661-62-1.
The listed molecular formula is C25H30ClN5O3.
The listed molecular weight is 484.00 g/mol.
8-chloro-1,3-dimethyl-7H-purine-2,6-dione;2-(1,1-diphenylethoxy)-N,N-dimethylethanamine.
The source lists moxastine teoclate and Mephenhydrinate.